Orlando L Catanzaro

Title: Orlando L Catanzaro: Innovator in B-Bradykinin Receptor Antagonists

Introduction

Orlando L Catanzaro is a notable inventor based in Buenos Aires, Argentina. He has made significant contributions to the field of pharmacology, particularly in the development of antagonists for the B-bradykinin receptor. His work addresses critical health issues related to inflammation and diabetes.

Latest Patents

Orlando L Catanzaro holds 1 patent related to novel antagonists to the B-bradykinin (B-BK) receptor. This invention demonstrates good affinity and selectivity for the receptor, with some compounds showing resistance to enzymatic degradation. The synthesis of B-receptors is induced during inflammation, which is a significant concern in diabetic animal models. His research confirms the presence of B-BK receptors in these models, and the antagonists developed have shown promising results in abolishing vasocontraction and normalizing glycemia in diabetic animals.

Career Highlights

Orlando is affiliated with the Université De Sherbrooke, where he continues to advance his research in this vital area of study. His innovative approach to addressing diabetic symptoms associated with inflammation has positioned him as a key figure in the field.

Collaborations

Orlando has collaborated with notable colleagues, including Domenico Recoli and Fernand Gobeil. Their combined expertise has contributed to the advancement of research in receptor antagonism and its therapeutic applications.

Conclusion

Orlando L Catanzaro's work in developing B-bradykinin receptor antagonists represents a significant advancement in treating conditions associated with inflammation and diabetes. His contributions continue to impact the field of pharmacology positively.